Investors locked in profits on Amarin Corp. (Nasdaq: AMRN). Shares of the biopharmaceutical fell 41 cents to $2.44.
Profit taking weighs down Amarin
March 17, 2015 at 13:26 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.